ARTICLE | Company News
Eli Lilly management changes
October 6, 2017 4:28 PM UTC
On Sept. 29, Eli Lilly and Co. (NYSE:LLY) announced several managerial changes, including the promotion of SVP of Clinical and Product Development Dan Skovronsky to SVP for science and technology and president of Lilly Research Labs to replace Jan Lundberg effective June 1, 2018.
Skovronsky joined Lilly in 2010 when the pharma acquired Avid Radiopharmaceuticals Inc. (see BioCentury, Nov. 15, 2010)...